Clinical Investigation Core
临床研究核心
基本信息
- 批准号:8259521
- 负责人:
- 金额:$ 64.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-15 至
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAdolescentApplications GrantsBehavioralBehavioral SciencesCaringChild health careClinicClinicalClinical DataClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunicable DiseasesConsultationsDataData AnalysesDatabasesDevelopmentElementsEligibility DeterminationEnrollmentEpidemiologyEvaluationFundingHIVHIV InfectionsHIV-1HumanIndividualInformation SystemsInstitutional Review BoardsInternationalIntervention StudiesLaboratoriesLifeLinkMedical centerMentorsPatientsPersonsPreparationPreventionPreventivePsychiatryPublicationsRecommendationResearchResearch DesignResearch PersonnelResearch Project GrantsResearch SubjectsResourcesRetrievalRiskSamplingScientistServicesSocial SciencesSpecimenSubstance abuse problemSystemTranslational Researchanalytical methodbehavioral/social scienceclinical careclinical research sitedesignhuman subjectinterestmeetingsmemberpopulation healthprogramsresearch studysocialsocial science researchuser-friendly
项目摘要
The primary objectives of the Clinical Investigation Core are to facilitate the ability of CFAR investigators
to initiate or expand HIV/AIDS research projects that require access to HIV-1 -infected individuals, clinical
specimens and/or or data, and to mentor junior and other new investigators in both clinical and social and
behavioral HIV-related research. The Core will provide CFAR members with access to robust databases with
demographic, clinical, and laboratory data from among patients and others enrolled in clinical research
studies. Queries to these databases can provide access to previously collected data and facilitate rapid
access to subjects who meet eligibility criteria for new studies. The clinical settings include the AIDS
Research Program of the Department of Epidemiology and Population Health, the Division of Substance
Abuse, the AIDS Center Infectious Diseases Clinic, the Adolescent AIDS Program, and a new Social and
Behavioral Component that includes the Prevention Intervention Research Center. The Core also will
provide assistance in study design, including recommendations for sample selection, power calculations and
the use of appropriate analytical methods. The Core has developed a centralized, user-friendly, efficient
gateway to provide access to data across clinical care and clinical research sites, to facilitate clinical
research, and to stimulate interactions among clinical and laboratory investigators to promote translational
research. Mentoring sessions at which senior investigators mentor junior and new investigators will continue.
Finally, the Core will facilitate new international research initiatives. The Specific Aims are: 1) To facilitate the
retrieval and sharing of clinical data currently available in disparate data systems; 2) To assist in identifying
individuals and/or their specimens for new research projects; 3) To expedite informing potential human
subjects of new and ongoing research projects and facilitate interactions between potential research subjects
and investigators; 4) To assist clinical, social science, and basic researchers in achieving rigor of study
design and validity and generalizability of study results by providing expertise in sample selection, study
design, power calculations, and appropriate analytical methods; 5) To mentor junior and new investigators in
all aspects of HIV-related research, including study design, subject enrollment, IRB requirements,
collaboration with basic scientists, preparation and resubmission of grant applications, and presentation and
publication of research findings; 6) To increase the capacity of investigators to perform studies involving
social and behavioral elements, and to build social science studies into existing or new clinical research,
through state-of-the-art consultation and support services in the social and behavioral sciences; 7) To
expand international HIV-related research; and 8) To educate clinicians about the latest developments in HIV
research to stimulate interest in investigating important unresolved clinical research questions.
临床研究核心的主要目标是促进CFAR研究者的能力
启动或扩展需要访问HIV -1感染者的艾滋病毒/艾滋病研究项目,临床
标本和/或数据,以及指导临床和社会和其他新调查员的指导
行为HIV相关的研究。核心将为CFAR成员提供对强大数据库的访问
来自患者和其他参与临床研究的患者的人口,临床和实验室数据
研究。这些数据库的查询可以提供对先前收集的数据的访问,并促进快速
访问符合新研究资格标准的受试者。临床设置包括艾滋病
流行病学和人口健康部研究计划,物质司
虐待,艾滋病中心传染病诊所,青少年艾滋病计划以及一个新的社会和
行为组成部分,包括预防干预研究中心。核心也将
在研究设计方面提供帮助,包括针对样品选择,电源计算和
使用适当的分析方法。核心已经开发了一种集中式,用户友好,高效的
网关可提供跨临床护理和临床研究站点的数据访问,以促进临床
研究,并刺激临床和实验室研究人员之间的相互作用以促进翻译
研究。指导会议将继续进行高级调查员指导初级和新调查人员的指导会议。
最后,核心将促进新的国际研究计划。具体目的是:1)促进
目前在不同数据系统中可用的临床数据的检索和共享; 2)协助识别
个人和/或其新研究项目的标本; 3)加快告知潜在人类的信息
新的和正在进行的研究项目的主题,并促进潜在研究对象之间的互动
和调查人员; 4)协助临床,社会科学和基础研究人员实现严格的研究
设计和有效性以及研究结果的有效性以及通过提供样本选择的专业知识,研究
设计,功率计算和适当的分析方法; 5)指导初级和新调查员
HIV相关研究的所有方面,包括研究设计,受试者注册,IRB要求,
与基础科学家合作,准备和重新提交赠款申请以及演示文稿以及
研究发现的出版; 6)提高调查人员进行涉及研究的能力
社会和行为因素,并将社会科学研究建立在现有或新的临床研究中,
通过最新的社会和行为科学咨询和支持服务; 7)
扩大国际HIV相关研究; 8)教育临床医生有关艾滋病毒的最新发展
刺激对研究重要未解决的临床研究问题的兴趣的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Stephen Klein其他文献
Robert Stephen Klein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Stephen Klein', 18)}}的其他基金
Artherosclerosis/bone loss/drug use/HIV in older men
老年男性的动脉粥样硬化/骨质流失/吸毒/艾滋病毒
- 批准号:
6736967 - 财政年份:2002
- 资助金额:
$ 64.67万 - 项目类别:
Artherosclerosis/bone loss/drug use/HIV in older men
老年男性的动脉粥样硬化/骨质流失/吸毒/艾滋病毒
- 批准号:
7050577 - 财政年份:2002
- 资助金额:
$ 64.67万 - 项目类别:
Artherosclerosis/bone loss/drug use/HIV in older men
老年男性的动脉粥样硬化/骨质流失/吸毒/艾滋病毒
- 批准号:
6655479 - 财政年份:2002
- 资助金额:
$ 64.67万 - 项目类别:
Artherosclerosis/bone loss/drug use/HIV in older men
老年男性的动脉粥样硬化/骨质流失/吸毒/艾滋病毒
- 批准号:
6891855 - 财政年份:2002
- 资助金额:
$ 64.67万 - 项目类别:
Artherosclerosis/bone loss/drug use/HIV in older men
老年男性的动脉粥样硬化/骨质流失/吸毒/艾滋病毒
- 批准号:
6622527 - 财政年份:2002
- 资助金额:
$ 64.67万 - 项目类别:
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 64.67万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 64.67万 - 项目类别:
Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
国家儿童医院基地联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599559 - 财政年份:2022
- 资助金额:
$ 64.67万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599556 - 财政年份:2022
- 资助金额:
$ 64.67万 - 项目类别: